Wasatch Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

Wasatch Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,369,260	Closed	-$176M	–	299
2021 Q1	$176M	Buy	7,369,260 +697,080	+10%	+$13M	0.79%	44
2020 Q4	$97.4M	Buy	6,672,180 +5,158,446	+341%	+$68.4M	0.48%	71
2020 Q3	$21.5M	Buy	1,513,734 +233,290	+18%	+$3.56M	0.14%	122
2020 Q2	$18.8M	Buy	+1,280,444	New	+$13M	0.14%	126

Wasatch Advisors's GNMK Position: Q2 2021 in Review

Wasatch Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 7,369,260 shares — an estimated $176M sold.

Wasatch Advisors first reported a position in GNMK in Q2 2020 and held it in 4 quarters. The position peaked at $176M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Wasatch Advisors reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Wasatch Advisors sold 7,369,260 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $176M.
Wasatch Advisors first reported a position in GenMark Diagnostics, Inc in Q2 2020 and held it in 4 quarters.
Wasatch Advisors's GenMark Diagnostics, Inc position peaked at $176M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Wasatch Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.